Search Results

CorriXR Therapeutics, Inc., an oncology-focused biotherapeutics company developing breakthrough technology that overcomes drug resistance in solid tumors, announced that Deborah Moorad, MBA, has been named the company’s new chief executive officer.

September 19, 2023

·

3 min read

Cancer of the brain as tumor growth diagnosis and symptoms of gliomas meningiomas astrocytomas and oligodendrogliomas as diagnosis of symptoms as a paper sculpture.

Brain cancer

Biopharma Takes on Deadly Brain Cancer After Decades of Failure

Emboldened by technological advances and a deeper knowledge of glioblastoma, Merck, Kazia Therapeutics, CorriXR Therapeutics and others are targeting the often-fatal brain tumor.

December 2, 2024

·

7 min read

·

Kate Goodwin

Business

ChristianaCare Spins Out First Commercial Gene Editing Biotechnology Start-Up Company, CorriXR Therapeutics

ChristianaCare, a leading non-profit health system in the mid-Atlantic region, today announced it has spun out its first commercial biotechnology private start-up company, named CorriXR Therapeutics.

October 11, 2022

·

5 min read